BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9226399)

  • 1. GIP(6-30amide) contains the high affinity binding region of GIP and is a potent inhibitor of GIP1-42 action in vitro.
    Gelling RW; Coy DH; Pederson RA; Wheeler MB; Hinke S; Kwan T; McIntosh CH
    Regul Pept; 1997 Apr; 69(3):151-4. PubMed ID: 9226399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the cellular and metabolic effects of a novel enzyme-resistant antagonist of glucose-dependent insulinotropic polypeptide.
    Gault VA; O'Harte FP; Harriott P; Flatt PR
    Biochem Biophys Res Commun; 2002 Feb; 290(5):1420-6. PubMed ID: 11820780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a bioactive domain in the amino-terminus of glucose-dependent insulinotropic polypeptide (GIP).
    Hinke SA; Manhart S; Pamir N; Demuth H; W Gelling R; Pederson RA; McIntosh CH
    Biochim Biophys Acta; 2001 May; 1547(1):143-55. PubMed ID: 11343800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional expression of the rat pancreatic islet glucose-dependent insulinotropic polypeptide receptor: ligand binding and intracellular signaling properties.
    Wheeler MB; Gelling RW; McIntosh CH; Georgiou J; Brown JC; Pederson RA
    Endocrinology; 1995 Oct; 136(10):4629-39. PubMed ID: 7664683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic AMP production and insulin releasing activity of synthetic fragment peptides of glucose-dependent insulinotropic polypeptide.
    Gault VA; Harriott P; Flatt PR; O'Harte FP
    Biosci Rep; 2002; 22(5-6):523-8. PubMed ID: 12635849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor.
    Gelling RW; Wheeler MB; Xue J; Gyomorey S; Nian C; Pederson RA; McIntosh CH
    Endocrinology; 1997 Jun; 138(6):2640-3. PubMed ID: 9165060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new pathway for glucose-dependent insulinotropic polypeptide (GIP) receptor signaling: evidence for the involvement of phospholipase A2 in GIP-stimulated insulin secretion.
    Ehses JA; Lee SS; Pederson RA; McIntosh CH
    J Biol Chem; 2001 Jun; 276(26):23667-73. PubMed ID: 11323439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminally and C-terminally truncated forms of glucose-dependent insulinotropic polypeptide are high-affinity competitive antagonists of the human GIP receptor.
    Hansen LS; Sparre-Ulrich AH; Christensen M; Knop FK; Hartmann B; Holst JJ; Rosenkilde MM
    Br J Pharmacol; 2016 Mar; 173(5):826-38. PubMed ID: 26572091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of glucose-dependent insulinotropic polypeptide (GIP).
    Hinke SA; Gelling R; Manhart S; Lynn F; Pederson RA; Kühn-Wache K; Rosche F; Demuth HU; Coy D; McIntosh CH
    Biol Chem; 2003 Mar; 384(3):403-7. PubMed ID: 12715891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding specificity and signal transduction of receptors for glucagon-like peptide-1(7-36)amide and gastric inhibitory polypeptide on RINm5F insulinoma cells.
    Gallwitz B; Witt M; Fölsch UR; Creutzfeldt W; Schmidt WE
    J Mol Endocrinol; 1993 Jun; 10(3):259-68. PubMed ID: 8396943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In depth analysis of the N-terminal bioactive domain of gastric inhibitory polypeptide.
    Hinke SA; Manhart S; Speck M; Pederson RA; Demuth HU; McIntosh CH
    Life Sci; 2004 Aug; 75(15):1857-70. PubMed ID: 15302229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human GIP(3-30)NH
    Gabe MBN; Sparre-Ulrich AH; Pedersen MF; Gasbjerg LS; Inoue A; Bräuner-Osborne H; Hartmann B; Rosenkilde MM
    Biochem Pharmacol; 2018 Apr; 150():97-107. PubMed ID: 29378179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat.
    Tseng CC; Kieffer TJ; Jarboe LA; Usdin TB; Wolfe MM
    J Clin Invest; 1996 Dec; 98(11):2440-5. PubMed ID: 8958204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GIP(3-30)NH
    Sparre-Ulrich AH; Gabe MN; Gasbjerg LS; Christiansen CB; Svendsen B; Hartmann B; Holst JJ; Rosenkilde MM
    Biochem Pharmacol; 2017 May; 131():78-88. PubMed ID: 28237651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of amino acid variants in the human glucose-dependent insulinotropic polypeptide (GIP) receptor: the impact on the pancreatic beta cell responses and functional expression studies in Chinese hamster fibroblast cells.
    Almind K; Ambye L; Urhammer SA; Hansen T; Echwald SM; Holst JJ; Gromada J; Thorens B; Pedersen O
    Diabetologia; 1998 Oct; 41(10):1194-8. PubMed ID: 9794107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dipeptidyl peptidase IV-resistant [D-Ala(2)]glucose-dependent insulinotropic polypeptide (GIP) improves glucose tolerance in normal and obese diabetic rats.
    Hinke SA; Gelling RW; Pederson RA; Manhart S; Nian C; Demuth HU; McIntosh CH
    Diabetes; 2002 Mar; 51(3):652-61. PubMed ID: 11872663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric inhibitory polypeptide stimulates glucocorticoid secretion in rats, acting through specific receptors coupled with the adenylate cyclase-dependent signaling pathway.
    Mazzocchi G; Rebuffat P; Meneghelli V; Malendowicz LK; Tortorella C; Gottardo G; Nussdorfer GG
    Peptides; 1999; 20(5):589-94. PubMed ID: 10465510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological and functional characteristics of a novel low-molecular weight antagonist of glucose-dependent insulinotropic polypeptide receptor, SKL-14959, in vitro and in vivo.
    Nakamura T; Tanimoto H; Mizuno Y; Tsubamoto Y; Noda H
    Diabetes Obes Metab; 2012 Jun; 14(6):511-7. PubMed ID: 22192426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cloning, functional expression, and signal transduction of the GIP-receptor cloned from a human insulinoma.
    Volz A; Göke R; Lankat-Buttgereit B; Fehmann HC; Bode HP; Göke B
    FEBS Lett; 1995 Oct; 373(1):23-9. PubMed ID: 7589426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GIP-(3-42) does not antagonize insulinotropic effects of GIP at physiological concentrations.
    Deacon CF; Plamboeck A; Rosenkilde MM; de Heer J; Holst JJ
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E468-75. PubMed ID: 16608883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.